Aclaris Therapeutics, Inc. (ACRS)
3.60
-0.23
(-6.01%)
USD |
NASDAQ |
Oct 12, 16:00
3.595
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Net Income (TTM) : -75.74M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -75.74M |
| March 31, 2026 | -69.66M |
| December 31, 2025 | -64.92M |
| September 30, 2025 | -141.68M |
| June 30, 2025 | -134.65M |
| March 31, 2025 | -130.21M |
| December 31, 2024 | -132.06M |
| September 30, 2024 | -37.00M |
| June 30, 2024 | -58.68M |
| March 31, 2024 | -77.26M |
| December 31, 2023 | -88.48M |
| September 30, 2023 | -114.62M |
| June 30, 2023 | -105.32M |
| March 31, 2023 | -96.28M |
| December 31, 2022 | -86.91M |
| September 30, 2022 | -82.08M |
| June 30, 2022 | -83.27M |
| March 31, 2022 | -80.90M |
| December 31, 2021 | -90.86M |
| September 30, 2021 | -81.66M |
| June 30, 2021 | -71.17M |
| Date | Value |
|---|---|
| March 31, 2021 | -64.58M |
| December 31, 2020 | -51.15M |
| September 30, 2020 | -56.73M |
| June 30, 2020 | -69.21M |
| March 31, 2020 | -101.33M |
| December 31, 2019 | -113.28M |
| September 30, 2019 | -118.78M |
| June 30, 2019 | -116.27M |
| March 31, 2019 | -103.80M |
| December 31, 2018 | -106.75M |
| September 30, 2018 | -105.01M |
| June 30, 2018 | -102.57M |
| March 31, 2018 | -86.19M |
| December 31, 2017 | -68.52M |
| September 30, 2017 | -57.06M |
| June 30, 2017 | -49.57M |
| March 31, 2017 | -47.60M |
| December 31, 2016 | -48.08M |
| September 30, 2016 | -41.32M |
| June 30, 2016 | -41.26M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 54.20M |
| Alumis, Inc. | -438.96M |
| ANI Pharmaceuticals, Inc. | 99.95M |
| Veru, Inc. | -14.11M |
| Johnson & Johnson | 21.04B |